AstraZeneca would like to inform you of an upcoming change to the NHS list price of Zoladex (goserelin) 3.6mg implant PFS, which will come into effect on 1 June.
We would like to reassure dispensing practices that this change will be fully reflected in Drug Tariff reimbursement, with reimbursement levels increasing in line with the updated NHS list price. Therefore, with the current commercial discount structure for Zoladex remaining unchanged, the established 22.5% discount off the NHS list price will result in an increased margin per pack. Please see details below.
| PIP code | Product Desc | NHS List (effective 1st June 2026) |
|---|---|---|
| 89797 | ZOLADEX 3.6MG SAFE SYSTEM SYR | £94.50 |
There are no changes to product presentation, prescribing guidance, supply arrangements, or availability for Zoladex. There are no changes to the NHS list price for Zoladex LA 10.8mg implant PFS.
Should you require any further clarification regarding this update, please contact AstraZeneca at supply.chain@astrazeneca.com.
Yours sincerely,
AstraZeneca UK Limited
GB-76635 – DOP: May 2026
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting contactazmedical.astrazeneca.com or by calling 0800 783 0033.